A vaccine targeting mutant IDH1 induces antitumour immunity
Heidelberg University · University Hospital Heidelberg · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
696
total citations
- FWCI
- 37.25
- Percentile
- 100%
- References
- 26
Citations per year
Authors
27- TSTheresa SchumacherCorresponding
Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases
- LBLukas Bunse
University Hospital Heidelberg, National Center for Tumor Diseases, Heidelberg University
- SPStefan Pusch
University Hospital Heidelberg, Heidelberg University, National Center for Tumor Diseases
- FSFelix Sahm
University Hospital Heidelberg, Heidelberg University, National Center for Tumor Diseases
- BWBenedikt Wiestler
National Center for Tumor Diseases, Heidelberg University, University Hospital Heidelberg
Topics & keywords
Topics
Keywords
- IDH1
- Cancer research
- MHC class I
- Biology
- Immunotherapy
- Mutation
- Isocitrate dehydrogenase
- Major histocompatibility complex
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.